Literature DB >> 17164340

T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.

Jonathan A Deane1, Michael G Kharas, Jean S Oak, Linda N Stiles, Ji Luo, Travis I Moore, Hong Ji, Christian Rommel, Lewis C Cantley, Thomas E Lane, David A Fruman.   

Abstract

The class IA subgroup of phosphoinositide 3-kinase (PI3K) is activated downstream of antigen receptors, costimulatory molecules, and cytokine receptors on lymphocytes. Targeted deletion of individual genes for class IA regulatory subunits severely impairs the development and function of B cells but not T cells. Here we analyze conditional mutant mice in which thymocytes and T cells lack the major class IA regulatory subunits p85alpha, p55alpha, p50alpha, and p85beta. These cells exhibit nearly complete loss of PI3K signaling downstream of the T-cell receptor (TCR) and CD28. Nevertheless, T-cell development is largely unperturbed, and peripheral T cells show only partial impairments in proliferation and cytokine production in vitro. Both genetic and pharmacologic experiments suggest that class IA PI3K signaling plays a limited role in T-cell proliferation driven by TCR/CD28 clustering. In vivo, class IA-deficient T cells provide reduced help to B cells but show normal ability to mediate antiviral immunity. Together these findings provide definitive evidence that class IA PI3K regulatory subunits are essential for a subset of T-cell functions while challenging the notion that this signaling mechanism is a critical mediator of costimulatory signals downstream of CD28.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17164340      PMCID: PMC1852227          DOI: 10.1182/blood-2006-07-038620

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  63 in total

Review 1.  Phosphoinositide 3-kinase signalling--which way to target?

Authors:  Matthias P Wymann; Marketa Zvelebil; Muriel Laffargue
Journal:  Trends Pharmacol Sci       Date:  2003-07       Impact factor: 14.819

2.  Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase.

Authors:  Jonathan A Deane; Matthew J Trifilo; Claudine M Yballe; Sangdun Choi; Thomas E Lane; David A Fruman
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

3.  Phosphatidylinositol 3-kinase regulates the CD4/CD8 T cell differentiation ratio.

Authors:  Luis Rodríguez-Borlado; Domingo F Barber; Carmen Hernández; Miguel A Rodríguez-Marcos; Arsenio Sánchez; Emilio Hirsch; Matthias Wymann; Carlos Martínez-A; Ana C Carrera
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

4.  The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest.

Authors:  Xianmin Xia; Aiwu Cheng; Damilola Akinmade; Anne W Hamburger
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

5.  The phospholipase C gamma 1-dependent pathway of Fc epsilon RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase.

Authors:  Christine Tkaczyk; Michael A Beaven; Saskia M Brachman; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Biol Chem       Date:  2003-09-16       Impact factor: 5.157

6.  Continuous T cell receptor signaling required for synapse maintenance and full effector potential.

Authors:  Johannes B Huppa; Michael Gleimer; Cenk Sumen; Mark M Davis
Journal:  Nat Immunol       Date:  2003-07-13       Impact factor: 25.606

7.  Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.

Authors:  Klaus Okkenhaug; Antonio Bilancio; Géraldine Farjot; Helen Priddle; Sara Sancho; Emma Peskett; Wayne Pearce; Stephen E Meek; Ashreena Salpekar; Michael D Waterfield; Andrew J H Smith; Bart Vanhaesebroeck
Journal:  Science       Date:  2002-07-18       Impact factor: 47.728

Review 8.  Phosphoinositide 3-kinase: diverse roles in immune cell activation.

Authors:  Jonathan A Deane; David A Fruman
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

9.  The CC chemokine ligand 3 regulates CD11c+CD11b+CD8alpha- dendritic cell maturation and activation following viral infection of the central nervous system: implications for a role in T cell activation.

Authors:  Matthew J Trifilo; Thomas E Lane
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

10.  Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system.

Authors:  William G Glass; Thomas E Lane
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

View more
  28 in total

1.  Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).

Authors:  Yenny Y Acosta; Maria Paz Zafra; Gloria Ojeda; Ilaria Seren Bernardone; Umberto Dianzani; Pilar Portolés; Jose M Rojo
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

Review 2.  Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase.

Authors:  J S Oak; M P Matheu; I Parker; M D Cahalan; D A Fruman
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

3.  mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.

Authors:  Hu Zeng; Sivan Cohen; Cliff Guy; Sharad Shrestha; Geoffrey Neale; Scott A Brown; Caryn Cloer; Rigel J Kishton; Xia Gao; Ben Youngblood; Mytrang Do; Ming O Li; Jason W Locasale; Jeffrey C Rathmell; Hongbo Chi
Journal:  Immunity       Date:  2016-09-13       Impact factor: 31.745

4.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

Review 5.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

Review 6.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

7.  Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1.

Authors:  Paoyun Tang; Julia E M Upton; Michelle A Barton-Forbes; Marina I Salvadori; Meghan P Clynick; April K Price; Sharan L Goobie
Journal:  J Clin Immunol       Date:  2017-11-25       Impact factor: 8.317

8.  T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase.

Authors:  Anjali J de Souza; Jean S Oak; Ryan Jordanhazy; Rosemarie H DeKruyff; David A Fruman; Lawrence P Kane
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.

Authors:  Carla Mouta-Bellum; Aleksander Kirov; Laura Miceli-Libby; Maria L Mancini; Tatiana V Petrova; Lucy Liaw; Igor Prudovsky; Philip E Thorpe; Naoyuki Miura; Lewis C Cantley; Kari Alitalo; David A Fruman; Calvin P H Vary
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

Review 10.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.